Copyright Reports & Markets. All rights reserved.

Global Micafungin Sodium API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Micafungin Sodium API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Micafungin Sodium API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Injection
    • 1.4.3 Powder for Infusion
  • 1.5 Global Micafungin Sodium API Market Size & Forecast
    • 1.5.1 Global Micafungin Sodium API Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Micafungin Sodium API Sales Quantity (2021-2032)
    • 1.5.3 Global Micafungin Sodium API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 MEDICHEM MANUFACTURING MALTA LTD
    • 2.1.1 MEDICHEM MANUFACTURING MALTA LTD Details
    • 2.1.2 MEDICHEM MANUFACTURING MALTA LTD Major Business
    • 2.1.3 MEDICHEM MANUFACTURING MALTA LTD Micafungin Sodium API Product and Services
    • 2.1.4 MEDICHEM MANUFACTURING MALTA LTD Micafungin Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 MEDICHEM MANUFACTURING MALTA LTD Recent Developments/Updates
  • 2.2 BIOCON LTD
    • 2.2.1 BIOCON LTD Details
    • 2.2.2 BIOCON LTD Major Business
    • 2.2.3 BIOCON LTD Micafungin Sodium API Product and Services
    • 2.2.4 BIOCON LTD Micafungin Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 BIOCON LTD Recent Developments/Updates
  • 2.3 TEVA PHARMACEUTICAL INDUSTRIES LTD
    • 2.3.1 TEVA PHARMACEUTICAL INDUSTRIES LTD Details
    • 2.3.2 TEVA PHARMACEUTICAL INDUSTRIES LTD Major Business
    • 2.3.3 TEVA PHARMACEUTICAL INDUSTRIES LTD Micafungin Sodium API Product and Services
    • 2.3.4 TEVA PHARMACEUTICAL INDUSTRIES LTD Micafungin Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
  • 2.4 MSN LIFE SCIENCES PRIVATE LTD
    • 2.4.1 MSN LIFE SCIENCES PRIVATE LTD Details
    • 2.4.2 MSN LIFE SCIENCES PRIVATE LTD Major Business
    • 2.4.3 MSN LIFE SCIENCES PRIVATE LTD Micafungin Sodium API Product and Services
    • 2.4.4 MSN LIFE SCIENCES PRIVATE LTD Micafungin Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 MSN LIFE SCIENCES PRIVATE LTD Recent Developments/Updates
  • 2.5 ZHEJIANG HISUN PHARMACEUTICAL
    • 2.5.1 ZHEJIANG HISUN PHARMACEUTICAL Details
    • 2.5.2 ZHEJIANG HISUN PHARMACEUTICAL Major Business
    • 2.5.3 ZHEJIANG HISUN PHARMACEUTICAL Micafungin Sodium API Product and Services
    • 2.5.4 ZHEJIANG HISUN PHARMACEUTICAL Micafungin Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 ZHEJIANG HISUN PHARMACEUTICAL Recent Developments/Updates
  • 2.6 SHANGHAI TECHWELL BIOPHARMACEUTICAL
    • 2.6.1 SHANGHAI TECHWELL BIOPHARMACEUTICAL Details
    • 2.6.2 SHANGHAI TECHWELL BIOPHARMACEUTICAL Major Business
    • 2.6.3 SHANGHAI TECHWELL BIOPHARMACEUTICAL Micafungin Sodium API Product and Services
    • 2.6.4 SHANGHAI TECHWELL BIOPHARMACEUTICAL Micafungin Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 SHANGHAI TECHWELL BIOPHARMACEUTICAL Recent Developments/Updates
  • 2.7 BRIGHTGENE BIO-MEDICAL TECHNOLOGY
    • 2.7.1 BRIGHTGENE BIO-MEDICAL TECHNOLOGY Details
    • 2.7.2 BRIGHTGENE BIO-MEDICAL TECHNOLOGY Major Business
    • 2.7.3 BRIGHTGENE BIO-MEDICAL TECHNOLOGY Micafungin Sodium API Product and Services
    • 2.7.4 BRIGHTGENE BIO-MEDICAL TECHNOLOGY Micafungin Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 BRIGHTGENE BIO-MEDICAL TECHNOLOGY Recent Developments/Updates
  • 2.8 JIANGSU HANSOH PHARMACEUTICAL GROUP
    • 2.8.1 JIANGSU HANSOH PHARMACEUTICAL GROUP Details
    • 2.8.2 JIANGSU HANSOH PHARMACEUTICAL GROUP Major Business
    • 2.8.3 JIANGSU HANSOH PHARMACEUTICAL GROUP Micafungin Sodium API Product and Services
    • 2.8.4 JIANGSU HANSOH PHARMACEUTICAL GROUP Micafungin Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 JIANGSU HANSOH PHARMACEUTICAL GROUP Recent Developments/Updates
  • 2.9 YUNG SHIN PHARMACEUTICAL INDUSTRIAL
    • 2.9.1 YUNG SHIN PHARMACEUTICAL INDUSTRIAL Details
    • 2.9.2 YUNG SHIN PHARMACEUTICAL INDUSTRIAL Major Business
    • 2.9.3 YUNG SHIN PHARMACEUTICAL INDUSTRIAL Micafungin Sodium API Product and Services
    • 2.9.4 YUNG SHIN PHARMACEUTICAL INDUSTRIAL Micafungin Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 YUNG SHIN PHARMACEUTICAL INDUSTRIAL Recent Developments/Updates
  • 2.10 Sichuan Novals Pharmaceuticals
    • 2.10.1 Sichuan Novals Pharmaceuticals Details
    • 2.10.2 Sichuan Novals Pharmaceuticals Major Business
    • 2.10.3 Sichuan Novals Pharmaceuticals Micafungin Sodium API Product and Services
    • 2.10.4 Sichuan Novals Pharmaceuticals Micafungin Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Sichuan Novals Pharmaceuticals Recent Developments/Updates
  • 2.11 Hangzhou Zhongmei Huadong Pharmaceutical
    • 2.11.1 Hangzhou Zhongmei Huadong Pharmaceutical Details
    • 2.11.2 Hangzhou Zhongmei Huadong Pharmaceutical Major Business
    • 2.11.3 Hangzhou Zhongmei Huadong Pharmaceutical Micafungin Sodium API Product and Services
    • 2.11.4 Hangzhou Zhongmei Huadong Pharmaceutical Micafungin Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Micafungin Sodium API by Manufacturer

  • 3.1 Global Micafungin Sodium API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Micafungin Sodium API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Micafungin Sodium API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Micafungin Sodium API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Micafungin Sodium API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Micafungin Sodium API Manufacturer Market Share in 2025
  • 3.5 Micafungin Sodium API Market: Overall Company Footprint Analysis
    • 3.5.1 Micafungin Sodium API Market: Region Footprint
    • 3.5.2 Micafungin Sodium API Market: Company Product Type Footprint
    • 3.5.3 Micafungin Sodium API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Micafungin Sodium API Market Size by Region
    • 4.1.1 Global Micafungin Sodium API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Micafungin Sodium API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Micafungin Sodium API Average Price by Region (2021-2032)
  • 4.2 North America Micafungin Sodium API Consumption Value (2021-2032)
  • 4.3 Europe Micafungin Sodium API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Micafungin Sodium API Consumption Value (2021-2032)
  • 4.5 South America Micafungin Sodium API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Micafungin Sodium API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Micafungin Sodium API Sales Quantity by Type (2021-2032)
  • 5.2 Global Micafungin Sodium API Consumption Value by Type (2021-2032)
  • 5.3 Global Micafungin Sodium API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Micafungin Sodium API Sales Quantity by Application (2021-2032)
  • 6.2 Global Micafungin Sodium API Consumption Value by Application (2021-2032)
  • 6.3 Global Micafungin Sodium API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Micafungin Sodium API Sales Quantity by Type (2021-2032)
  • 7.2 North America Micafungin Sodium API Sales Quantity by Application (2021-2032)
  • 7.3 North America Micafungin Sodium API Market Size by Country
    • 7.3.1 North America Micafungin Sodium API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Micafungin Sodium API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Micafungin Sodium API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Micafungin Sodium API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Micafungin Sodium API Market Size by Country
    • 8.3.1 Europe Micafungin Sodium API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Micafungin Sodium API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Micafungin Sodium API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Micafungin Sodium API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Micafungin Sodium API Market Size by Region
    • 9.3.1 Asia-Pacific Micafungin Sodium API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Micafungin Sodium API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Micafungin Sodium API Sales Quantity by Type (2021-2032)
  • 10.2 South America Micafungin Sodium API Sales Quantity by Application (2021-2032)
  • 10.3 South America Micafungin Sodium API Market Size by Country
    • 10.3.1 South America Micafungin Sodium API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Micafungin Sodium API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Micafungin Sodium API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Micafungin Sodium API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Micafungin Sodium API Market Size by Country
    • 11.3.1 Middle East & Africa Micafungin Sodium API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Micafungin Sodium API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Micafungin Sodium API Market Drivers
  • 12.2 Micafungin Sodium API Market Restraints
  • 12.3 Micafungin Sodium API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Micafungin Sodium API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Micafungin Sodium API
  • 13.3 Micafungin Sodium API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Micafungin Sodium API Typical Distributors
  • 14.3 Micafungin Sodium API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Micafungin Sodium API market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Micafungin Sodium API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Micafungin Sodium API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Micafungin Sodium API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Micafungin Sodium API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Micafungin Sodium API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Micafungin Sodium API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Micafungin Sodium API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MEDICHEM MANUFACTURING MALTA LTD, BIOCON LTD, TEVA PHARMACEUTICAL INDUSTRIES LTD, MSN LIFE SCIENCES PRIVATE LTD, ZHEJIANG HISUN PHARMACEUTICAL, SHANGHAI TECHWELL BIOPHARMACEUTICAL, BRIGHTGENE BIO-MEDICAL TECHNOLOGY, JIANGSU HANSOH PHARMACEUTICAL GROUP, YUNG SHIN PHARMACEUTICAL INDUSTRIAL, Sichuan Novals Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Micafungin Sodium API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥99%
    Purity<99%
    Market segment by Application
    Injection
    Powder for Infusion
    Major players covered
    MEDICHEM MANUFACTURING MALTA LTD
    BIOCON LTD
    TEVA PHARMACEUTICAL INDUSTRIES LTD
    MSN LIFE SCIENCES PRIVATE LTD
    ZHEJIANG HISUN PHARMACEUTICAL
    SHANGHAI TECHWELL BIOPHARMACEUTICAL
    BRIGHTGENE BIO-MEDICAL TECHNOLOGY
    JIANGSU HANSOH PHARMACEUTICAL GROUP
    YUNG SHIN PHARMACEUTICAL INDUSTRIAL
    Sichuan Novals Pharmaceuticals
    Hangzhou Zhongmei Huadong Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Micafungin Sodium API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Micafungin Sodium API, with price, sales quantity, revenue, and global market share of Micafungin Sodium API from 2021 to 2026.
    Chapter 3, the Micafungin Sodium API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Micafungin Sodium API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Micafungin Sodium API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Micafungin Sodium API.
    Chapter 14 and 15, to describe Micafungin Sodium API sales channel, distributors, customers, research findings and conclusion.

    Buy now